Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

A safe vaccine called BCG, consisting of a weakened strain of the closely related Mycobacterium bovis, has been available for ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

District Immunization Officer Dr. Ravi Kumar Naik emphasized that complete immunization for every child in Nagarkurnool ...